SEP 5, 2026 · JOURNAL ARTICLE
Proteogenomic profiling defines progression-associated biology in high-risk endometrial cancer
npj Precision Oncology
A well-designed retrospective proteogenomic study with independent validation cohort showing that proteomic profiling improves risk stratification beyond clinical-genomic classifiers in high-risk endometrial cancer, but limited by single-center design, archival tissue, and lack of prospective validation or intervention outcome data.
Reported
Training cohort sample size274
Independent validation cohort sam…73
Stage distributionStage I-III